Skip to main navigation Skip to search Skip to main content

New insights of CYP1A in endogenous metabolism: a focus on single nucleotide polymorphisms and diseases

  • Jian Lu
  • , Xuyang Shang
  • , Weiguo Zhong
  • , Yuan Xu
  • , Rong Shi
  • , Xin Wang*
  • *Corresponding author for this work
  • East China Normal University
  • Shanghai University of Traditional Chinese Medicine

Research output: Contribution to journalReview articlepeer-review

Abstract

Cytochrome P450 1A (CYP1A), one of the major CYP subfamily in humans, not only metabolizes xenobiotics including clinical drugs and pollutants in the environment, but also mediates the biotransformation of important endogenous substances. In particular, some single nucleotide polymorphisms (SNPs) for CYP1A genes may affect the metabolic ability of endogenous substances, leading to some physiological or pathological changes in humans. This review first summarizes the metabolism of endogenous substances by CYP1A, and then introduces the research progress of CYP1A SNPs, especially the research related to human diseases. Finally, the relationship between SNPs and diseases is discussed. In addition, potential animal models for CYP1A gene editing are summarized. In conclusion, CYP1A plays an important role in maintaining the health in the body.

Original languageEnglish
Pages (from-to)91-104
Number of pages14
JournalActa Pharmaceutica Sinica B
Volume10
Issue number1
DOIs
StatePublished - Jan 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • CYP1A
  • Endogenous substances
  • Metabolism and disease
  • SNPs
  • Xenobiotics

Fingerprint

Dive into the research topics of 'New insights of CYP1A in endogenous metabolism: a focus on single nucleotide polymorphisms and diseases'. Together they form a unique fingerprint.

Cite this